WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

PIMAVANSERIN IN THE MANAGEMENT OF PSYCHOSIS IN PARKINSONIAN PATIENTS

Chaithanya T. K., Sam C. P.* and Sambathkumar R.

ABSTRACT

Parkinson’s disease psychosis or PDP is a condition that may develop in about 60 % of the Parkinson’s patients. Parkinson’s disease is often associated with hallucinations and psychosis. Atypical and typical antipsychotics were used to manage these symptoms. Recently US FDA has approved a new drug pimavanserin for the treatment of hallucination and delusion associated with parkinson’s disease psychosis. Pimavanserin is an NME (New Molecular Entity) that has not been approved elsewhere in the world for any other indication. It is the first anti-psychotic drug without dopamine blockade. With its highly targeted and selective receptor binding profile, pimavanserin provides a promising approach to the treatment of psychosis in parkinsonian patients, a condition which clearly lacks effective treatment options. However, it isnot approved for the treatment ofpatients with dementia related psychosisunrelated to hallucinations and delusionsassociated with Parkinson’s disease.

Keywords: Pimavanserin, psychosis, parkinsonism, hallucinations and delusions.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More